All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
| YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
| PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
|
|
|
|
|
|
|
|
| VYGR / Voyager Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TBIO / Telesis Bio, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CLR / Continental Resources Inc (OKLA)
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| WKHS / Workhorse Group Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
| US26885B1008 / EQT Midstream Partners LP
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
| GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ETRN / Equitrans Midstream Corporation
|
|
|
|
|
|
|
|
| IFRX / InflaRx N.V.
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| PGNY / Progyny, Inc.
|
|
|
|
|
|
|
|
| AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
| OVV / Ovintiv Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
